Rua Life Sciences PLC (LSE:RUA) — Stock Price
Rua Life Sciences PLC (LSE:RUA) is currently trading at GBX24.50 GBX, up 2.08% today. Over the past 52 weeks, shares have ranged between GBX10.50 and GBX25.50. This page tracks Rua Life Sciences PLC's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see RUA market cap overview.
Rua Life Sciences PLC (RUA) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Rua Life Sciences PLC's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Rua Life Sciences PLC Income Statement — Revenue, Profit & Earnings by Year
Rua Life Sciences PLC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Total Revenue | GBX4.46 Million | GBX4.46 Million | GBX4.11 Million | GBX2.19 Million | GBX2.18 Million |
| Cost of Revenue | GBX1.40 Million | GBX1.40 Million | GBX941.00K | GBX475.00K | GBX746.00K |
| Gross Profit | GBX3.06 Million | GBX3.06 Million | GBX3.17 Million | GBX1.72 Million | GBX1.43 Million |
| Research & Development | — | — | — | GBX887.00K | GBX1.09 Million |
| SG&A | — | — | GBX4.16 Million | GBX1.15 Million | GBX1.09 Million |
| Total Operating Expenses | GBX3.88 Million | GBX3.88 Million | GBX3.19 Million | GBX3.40 Million | GBX3.82 Million |
| Operating Income | GBX-826.67K | GBX-826.67K | GBX-989.00K | GBX-1.94 Million | GBX-2.31 Million |
| EBITDA | GBX-383.33K | GBX-383.33K | GBX401.00K | GBX-1.57 Million | GBX-1.95 Million |
| EBIT | GBX-826.67K | GBX-826.67K | GBX-20.00K | GBX-1.94 Million | GBX-2.31 Million |
| Interest Expense | — | — | — | GBX83.00K | GBX16.00K |
| Income Before Tax | GBX-157.33K | GBX-157.33K | GBX-10.00K | GBX-2.02 Million | GBX-2.32 Million |
| Income Tax Expense | GBX-2.00K | GBX-2.00K | GBX11.00K | GBX-580.00K | GBX-319.00K |
| Net Income | GBX-145.33K | GBX-145.33K | GBX1.00K | GBX-1.44 Million | GBX-2.00 Million |
Rua Life Sciences PLC Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Rua Life Sciences PLC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | GBX9.12 Million | GBX9.26 Million | GBX8.17 Million | GBX5.66 Million | GBX7.63 Million |
| Total Current Assets | GBX5.39 Million | GBX5.41 Million | GBX4.99 Million | GBX2.15 Million | GBX4.21 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | GBX1.25 Million | GBX1.09 Million | GBX532.00K | GBX588.00K | GBX1.12 Million |
| Inventory | GBX894.00K | GBX754.00K | GBX112.00K | GBX81.00K | GBX124.00K |
| Property, Plant & Equipment | — | — | — | — | GBX2.60 Million |
| Goodwill | GBX301.00K | GBX301.00K | GBX301.00K | GBX301.00K | GBX301.00K |
| Total Liabilities | GBX1.89 Million | GBX1.86 Million | GBX987.00K | GBX980.00K | GBX1.04 Million |
| Total Current Liabilities | GBX1.16 Million | GBX1.10 Million | GBX554.00K | GBX414.00K | GBX511.00K |
| Long-term Debt | — | — | GBX132.00K | GBX165.00K | GBX199.00K |
| Net Debt | GBX-2.46 Million | GBX-2.54 Million | GBX-3.54 Million | GBX-1.01 Million | GBX-2.62 Million |
| Total Stockholder Equity | GBX7.14 Million | GBX7.30 Million | GBX7.18 Million | GBX4.68 Million | GBX6.58 Million |
| Retained Earnings | GBX-20.20 Million | GBX-19.98 Million | GBX-19.98 Million | GBX-18.55 Million | GBX-16.54 Million |
Rua Life Sciences PLC Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Rua Life Sciences PLC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | GBX-137.00K | GBX-219.00K | GBX-1.33 Million | GBX-1.17 Million | GBX-2.36 Million |
| Capital Expenditures | GBX161.00K | GBX62.00K | GBX55.00K | GBX449.00K | GBX904.00K |
| Free Cash Flow | GBX-298.00K | GBX-281.00K | GBX-1.38 Million | GBX-1.62 Million | GBX-3.27 Million |
| Investing Cash Flow | GBX-59.00K | GBX70.00K | GBX-85.00K | GBX-449.00K | GBX-904.00K |
| Financing Cash Flow | GBX-459.00K | GBX-196.00K | GBX3.89 Million | GBX132.00K | GBX-66.00K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | GBX110.00K | GBX-35.00K | GBX102.00K | GBX145.00K |
| Depreciation | GBX443.33K | GBX421.00K | GBX364.00K | GBX358.00K | GBX313.00K |
| Change in Cash | GBX-681.00K | GBX-364.00K | GBX2.45 Million | GBX-1.48 Million | GBX-3.33 Million |
Rua Life Sciences PLC Earnings History — EPS Actual vs. Analyst Estimates
Track Rua Life Sciences PLC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jan 25, 2027 | — | — | — |
| Jun 13, 2026 | — | — | — |
| Jan 25, 2026 | — | — | — |
| Jun 15, 2025 | -0.01 | — | — |
| Dec 11, 2024 | 0.01 | 0.00 | — |
| Jul 26, 2023 | 0.00 | 0.00 | — |
| Dec 12, 2022 | -0.05 | — | — |
| Jul 18, 2022 | -0.03 | — | — |